Our recent work also supported this notion, where we demonstrated the abnormal expression of ERBB proteins and showed that the expression of ERBB3 was associated with patient survival and could serve as a novel and valuable predictor for prognostic evaluation of patients with NPC [26]. This evidence concerns the gene EGFR and nasopharyngeal carcinoma.